163 Is the current 2 week wait cancer referral (2WW referral) fit for purpose in malignant brain tumour referrals?
The 2WW pathway aims to ensure timely assessment of patients following referral from primary care with suspected malignant tumours of brain and central nervous system. NICE guidance CG121 is designed to avoid inappropriate referrals, delays and to reduce patient anxiety avoiding longer waits. This audit evaluated...